EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa
Abstract
British Journal of DermatologyVolume 182, Issue 3 p. 794-797 Research Letter EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa S. Gaucher, S. Gaucher orcid.org/0000-0002-3484-3239 INSERM UMR 1163, Laboratory of Genetic Skin Diseases, Imagine Institute, Paris, France University Paris Descartes-Sorbonne Paris Cité, Paris, France Service de...
Paper Details
Title
EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa
Published Date
Nov 27, 2019
Volume
182
Issue
3
Pages
794 - 797
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History